Upload
kushal
View
213
Download
0
Embed Size (px)
Citation preview
REVIEW
Yoga and meditation in cardiovascular disease
S. C. Manchanda • Kushal Madan
Received: 11 September 2013 / Accepted: 3 January 2014
� Springer-Verlag Berlin Heidelberg 2014
Abstract Yoga is a holistic mind–body intervention
aimed at physical, mental, emotional and spiritual well
being. Several studies have shown that yoga and/or medi-
tation can control risk factors for cardiovascular disease
like hypertension, type II diabetes and insulin resistance,
obesity, lipid profile, psychosocial stress and smoking.
Some randomized studies suggest that yoga/meditation
could retard or even regress early and advanced coronary
atherosclerosis. A recent study suggests that transcendental
meditation may be extremely useful in secondary preven-
tion of coronary heart disease and may reduce cardiovas-
cular events by 48 % over a 5-year period. Another small
study suggests that yoga may be helpful in prevention of
atrial fibrillation. However, most studies have several
limitations like lack of adequate controls, small sample
size, inconsistencies in baseline and different methodolo-
gies, etc. and therefore large trials with improved meth-
odologies are required to confirm these findings. However,
in view of the existing knowledge and yoga being a cost-
effective technique without side effects, it appears appro-
priate to incorporate yoga/meditation for primary and
secondary prevention of cardiovascular disease.
Keywords Hatha yoga � Transcendental meditation �Hypertension � Metabolic syndrome � Dyslipidemia �Coronary heart disease
Yoga and meditation in cardiovascular disease
The word ‘Yoga’ comes from a Sanskrit word ‘YUG’
which means to yoke or join together. It connotes joining
the lower human nature to the higher [1]. Originating in
India about 4,000 years ago, the practice of yoga has
become increasingly common in the western countries [2–
6]. Ancient texts have described several types of yogic
practices. These include
Bhakti Yoga emphasizes devotion and spirituality
Gnana Yoga emphasizes wisdom
Karma Yoga emphasizes self-less services, offerings
Raj Yoga emphasizes mastery of mind by focused
concentration
Dhyana Yoga emphasizes meditation
Mantra Yoga emphasizes repetition of sacred recitation
like trancendental meditation and
Hatha Yoga emphasizes psychosocial energies of body
[1, 7]
Hatha yoga is most commonly practiced in the western
countries and which itself includes many different styles
(e.g. Iyenger, Ashtang, Anasara, Kundalini, Integral and
Bikram yoga which is practiced in very high temperatures
and may not be suitable for cardiac patients). Core com-
ponents of Hatha yoga include stretching exercises and
physical postures (Asanas), breath control (Pranayama) and
concentration and thinking techniques (Meditation)
designed to promote physical, mental, emotional and
spiritual well being. Yoga is believed to help detoxify the
body, mitigate chronic fatigue, enhance endurance and
improve organ and immune functions [7]. Beneficial
effects of yoga/meditation have also been reported in
allergies, asthma, anxiety, depression, acid peptic disease,
irritable bowel syndrome, migraine, diabetes mellitus,
cardiovascular disease (CVD), etc. [8]. Yoga appears to be
S. C. Manchanda (&) � K. Madan
Dharma Vira Heart Center, Sir Ganga Ram Hospital,
New Delhi 110060, India
e-mail: [email protected]
123
Clin Res Cardiol
DOI 10.1007/s00392-014-0663-9
especially beneficial for CVD. This article will review the
evidence-based usefulness of yoga in the primary and
secondary prevention of CVD.
The literature search was focused on recent research that
primarily assessed the effects of yoga/meditation on risk
factors for coronary heart disease and secondary prevention
studies. Articles were identified using MEDLINE, Pub-
Med. As a number of studies investigating the effect of
yoga have been conducted in Indian subcontinent and these
databases offer only incomplete capture of articles pub-
lished in Indian Medical Journals, IndMED a bibliographic
database of over 75 Indian biomedical journals was also
searched.
Yoga for control of risk factors for CVD
Modern lifestyle stresses have been shown to be major
contributory factors to many diseases including CVD.
A US-based study has shown that mindfulness-based stress
reduction (MBSR) such as yoga reduced the average
number of visits to primary care physicians in inner city
areas suggesting that yoga may contribute in general health
and particularly in cardiac health in populations that are
subject to significant mental stress [9]. Many other studies
suggest that yoga/meditation practices can control heart
disease risk factors like hypertension, diabetes mellitus,
metabolic syndrome, obesity, psychosocial stress, dyslipi-
demia, oxidative stress, etc. and which are discussed
below.
Yoga and hypertension
Several controlled and uncontrolled studies have shown the
short- and long-term usefulness of yoga in the treatment of
hypertension [10–30]. In earlier studies Shavasana (Corpse
posture) and transcendental medication (TM) were repor-
ted to lower both systolic and diastolic blood pressure
significantly [10, 11]. Many randomized trials and meta-
analyses have also demonstrated a modest but consistent
decrease in blood pressure with yoga/meditation [10–30].
In a randomized trial, yoga was found to be equally
effective as anti hypertensive therapy over 11 week period
[19]. Another randomized controlled trial demonstrated
that yoga and biofeedback were capable of producing long-
term beneficial effect in the treatment of hypertension [29].
A meta-analysis involving nine well-controlled randomized
trials showed that TM compared to control was associated
with a decrease of systolic blood pressure of 4.7 mmHg (CI
1.9–7.4) and diastolic blood pressure of 3.2 mmHg (CI
1.3–5.6) [28]. Although the reduction in blood pressure by
yoga and meditation is modest, this could significantly
decrease the risk of CVD, because it has been estimated
that reducing systolic blood pressure by 3 mmHg in gen-
eral population has the potential to reduce stroke mortality
by 8 % and coronary heart disease (CHD) by 5 % [31, 32].
The possible mechanism of reduction of blood pressure is
considered to be reduced sympathetic activity and resto-
ration of baroreceptor sensitivity by yoga [17].
Yoga and metabolic syndrome
Metabolic syndrome is a strong risk factor of coronary
heart disease and type 2 diabetes mellitus. Regular practice
of yoga/TM have been shown to improve several compo-
nents of metabolic syndrome like insulin resistance, body
mass index, waist circumference, dyslipidemia, blood
pressure and HbA1c [33–37]. Yoga has also been reported
to regress early atherosclerosis in metabolic syndrome as
assessed by carotid intimal-medial thickness [37].
Yoga and type 2 diabetes mellitus
Yoga has been shown to be a simple and cost-effective
therapeutic modality as an adjuvant for type 2 diabetes
mellitus (DM) patients [38–42]. In a group of diabetics
who practiced yoga regularly, there was a reduction in
hyperglycemia and decrease in oral hypoglycemic drugs to
maintain adequate blood sugar control [38].
Yoga and body weight
Body weight and composition have been shown to be
consistently improved by yogic intervention. Five RCT’s
[43–46] have demonstrated an improvement in body
weight and/or composition relative to controls. These
studies have been performed in healthy individuals as well
as those with hypertension and other CVD risk factors, type
2 diabetes mellitus and CHD. Yoga was associated with
1.5–13.5 % decrease in body weight.
Yoga and lipid profile
Practice of yoga and yoga-based programs may improve
lipid profiles in healthy adults and in patients with diabetes,
hypertension and CHD. Four uncontrolled and four con-
trolled studies that range from 6 weeks to 12 months in
duration showed significant improvement in lipid profile
(reduction in LDL-c and triglycerides (Tg) and increase in
HDL-c over control values [44, 47–49]. Several RCTs
investigating the effect of yoga in combination with diet,
Clin Res Cardiol
123
education, stress management and other therapies have
likewise demonstrated a significant improvement in lipid
profiles relative to controls receiving usual care. The
magnitude of reduction of total cholesterol has varied
between 5.8 and 25.2 %, Tg between 22.0 and 28.5 % and
LDL-c by 12.8–26 % in these studies. A recent randomized
parallel study has also demonstrated a significant decrease
in total cholesterol, Tg and LDL-c with an improvement of
HDL-c in diabetic patients with dyslipidemia [50].
Yoga and psychosocial stress
Psychosocial stress is a significant major predictor of
hypertension, stroke, myocardial infarction, insulin resis-
tance and cardiovascular mortality. There is a strong
experimental evidence to suggest that yoga can lead to
improvement in both cardiovascular response to stress and
cardiovascular recovery from stress [51–53]. Several
studies also suggest that stress can be reduced significantly
with regular practice of yoga and meditation [5, 7, 8].
Yoga and procoagulant changes and oxidative stress
Procoagulant changes and damage caused by oxidative
stress have a pivotal role in the causation of metabolic
syndrome and development and progression of CVD and
diabetes [54]. In an uncontrolled study, it was observed that
16 weeks of yogic practices caused a significant decline in
fibrinogen and increase in fibrinolytic activity [55]. In
another non-randomized study of healthy German adults it
was demonstrated that 3-month residential Kriya yoga
program resulted in a significant fall in fibrinogen relative
to controls [56]. These trials suggest that yoga may foster
beneficial changes in the coagulation and fibrinogen system
in healthy adults.
Results of some small studies [42, 45, 46, 57–60] pro-
vide evidence that yoga may reduce oxidative stress in both
healthy populations and chronic insulin resistance-related
disorders. Observed changes in other oxidative stress
indices include increase in antioxidants and antioxidative
enzymes and reduction of free radicals.
Yoga and regression of atherosclerosis
Two randomized trials have shown that the early athero-
sclerosis (as assessed by carotid intimal-medial thickness
cIMT) is significantly reduced by regular practice of yoga/
meditation [37, 61]. Fields et al. showed that after 9-month
Multi Modality Natural Medicine program including TM,
cIMT was significantly reduced. Manchanda et al. [37]
demonstrated that 1-year practice of yoga significantly
reduced cIMT in patients with metabolic syndrome as
compared to controls.
Three controlled studies utilizing coronary angiography
in advanced atherosclerotic coronary heart disease have
demonstrated that regular practice of yoga/meditation with
use of low fat vegetarian diet caused retardation of pro-
gression and/or regression of coronary obstructions as
compared to the usual care control group [43, 62, 63]. In
addition the need for interventional procedures was sig-
nificantly reduced. LDL-c, Tg, body weight, angina and
exercise induced ischemia were also significantly reduced
in the yoga group. All three studies reported excellent
compliance with yoga practices and no side effect were
reported in patients with significant coronary obstructive
disease.
Yoga and secondary prevention
In a recent randomized controlled trial of TM and health
education in Blacks, it has been reported that there was a
48 % risk reduction in primary end point which was
composite of all cause mortality, myocardial infarction and
stroke over a period of 5.4 years [64].
In addition there was significant reduction in systolic
blood pressure and anger expression. This study suggests
that meditation may be useful for secondary prevention of
coronary heart disease.
Yoga and cardiac rehabilitation
Cardiac rehabilitation has been shown to be beneficial in
recovery process after myocardial infarction. Among its
component interventions, evidence suggests that exercise
may have a stronger effect on mortality, while psychosocial
interventions act more on quality of life measures. Yoga
practice leads to similar outcomes as cardiac rehabilitation
(improved physical fitness, stress reduction and lifestyle
change). Yoga has contributed to general well being,
decreased physiological arousal, better sleep and appetite
[65–67]. Yoga, therefore, could provide a useful frame-
work to develop an economical cardiac rehabilitation
programme.
Yoga and smoking
A recent randomized controlled trial has suggested that a
brief training of mindfulness meditation produced a sig-
nificant reduction of smoking by 60 % and also curbed
craving in smokers [68]. These changes were probably
Clin Res Cardiol
123
related to improved self-control as suggested by increased
activity in the anterior cingulate and prefrontal cortex in
functional MRI.
Yoga and arrhythmias
A small study (Yoga MYHEART Study) has suggested that
yoga may decrease the arrhythmia burden, anxiety, depression
and improve quality of life in paroxysmal atrial fibrillation,
suggesting that yoga may be useful in some arrhythmias by its
influence on the autonomic nervous system [69].
Possible mechanisms of action of yoga
Although the mechanisms underlying the potential beneficial
effects of yoga on cardiovascular risk profile are not yet well
understood, the observed changes probably occur primarily
through two pathways. First, by reducing activation and
reactivity of the sympathoadrenal system and hypothalamic
pituitary adrenal (HPA) axis and promoting feelings of well
being, yoga may alleviate the effects of stress and foster
multiple positive downstream effects on neuroendocrine sta-
tus, metabolic function and related inflammatory responses;
second, by directly stimulating the vagus nerve yoga may
enhance parasympathetic output and thereby shift the auto-
nomic nervous system balance from primarily sympathetic to
parasympathetic leading to positive changes in cardiac vagal
functions, mood and energy state and in related neuroendo-
crine, metabolic and inflammatory responses.
Limitations of yoga studies
Although yoga/meditation has been found to be useful in
many cardiovascular disease states, there are several limi-
tations of reported studies. Most of the studies have small
sample size and have inconsistencies in baseline; many have
absence of adequate controls and non uniform methodolo-
gies. Meta-analyses of yoga studies have similar limitations.
Larger multicenter randomized studies are needed to confirm
these findings. However as yoga/meditation is a cost-effec-
tive, simple technique without any side effects and hence
could be recommended for primary and secondary preven-
tion of cardiovascular disease and that it can play a primary
or complimentary role in this regard [70].
Conclusion
Yoga is a mind–body technique and meditation is an
important component of yoga. Many studies suggest that
yoga/meditation may be helpful in controlling several risk
factors for coronary heart disease like hypertension, type 2
DM, dyslipidemia, oxidative and psychosocial stress,
obesity and smoking. Yoga/meditation has also been
shown to be beneficial in secondary prevention of CHD
and even in paroxysmal atrial fibrillation. Yoga may even
regress atherosclerosis. However, there are several limita-
tions of the reported studies and larger studies are needed
to confirm these findings.
Conflict of interest On behalf of all authors, the corresponding
author states that there is no conflict of interest.
References
1. Ananda S (1981) The Complete book of yoga: Harmony of body
and mind, 1st edn. Orient, Delhi reprinted 2001
2. Garfinkel M, Schumacher HR Jr (2000) Yoga. Rheum Dis Clin N
Am 26:125–132
3. Chandler K (2001) The emerging field of yoga therapy. Hawaii
Med J 60:286–287
4. Mak JC, Faux S (2010) Complementary and alternative medicine
use by osteoporotic patients in Australia (CAMEO-A): a pro-
spective study. J Altern Complement Med 16(5):579–584
5. Michalsen A, Grossman P, Acil A, Langhorst J, Ludtke R, Esch T
et al (2005) Rapid stress reduction and anxiolysis among dis-
tressed women as a consequence of a three-month intensive yoga
program. Med Sci Monit 11(12):CR555–CR561
6. Hoyez AC (2007) The ‘world of yoga’: the production and
reproduction of therapeutic landscapes. Soc Sci Med 65(1):
112–124
7. Raub J (2002) Psychophysiologic effects of Hatha Yoga on
musculoskeletal and cardiopulmonary function: a literature
review. J Altern Complement Med 8:797–812
8. Meditation practices for Health. State of the Research (2007)
prepared for agency for Healthcare Research and Quantity; US
Department of Health and Human Services. www.ahrg.gov
9. Roth B, Stanley TW (2002) Mindfulness-based stress reduction
and healthcare utilization in the inner city: preliminary findings.
Altern Ther Health Med 8(1):60-2–64-6
10. Datey KK, Deshmukh SN, Dalvi CP, Vinekar SL (1969)
‘‘Shavasan’’: a yogic exercise in the management of hyperten-
sion. Angiology 20(6):325–333
11. Benson H, Rosner BA, Marzetta BR, Klemchuk HM (1974)
Decreased blood-pressure in pharmacologically treated hyper-
tensive patients who regularly elicited the relaxation response.
Lancet 1(7852):289–291
12. Glasgow MS, Gaarder KR, Engel BT (1982) Behavioral treat-
ment of high blood pressure II. Acute and sustained effects of
relaxation and systolic blood pressure biofeedback. Psychosom
Med 44(2):155–170
13. Patel C, North WR (1975) Randomised controlled trial of yoga
and bio-feedback in management of hypertension. Lancet
2(7925):93–95
14. Eisenberg DM, Delbanco TL, Berkey CS, Kaptchuk TJ, Kupel-
nick B, Kuhl J et al (1993) Cognitive behavioral techniques for
hypertension: are they effective? Ann Intern Med 118(12):
964–972
15. Bagga OP, Gandhi A (1983) A comparative study of the effect of
Transcendental Meditation (TM) and Shavasana practice on
cardiovascular system. Indian Heart J 35(1):39–45
Clin Res Cardiol
123
16. Johnston SW (1987) The behavioural control of high blood
pressure. Curr Pychol Res Rev 6:99–114
17. Selvamurthy W, Sridharan K, Ray US, Tiwary RS, Hegde KS,
Radhakrishan U et al (1998) A new physiological approach to
control essential hypertension. Indian J Physiol Pharmacol
42(2):205–213
18. Sundar S, Agrawal SK, Singh VP, Bhattacharya SK, Udupa KN,
Vaish SK (1984) Role of yoga in management of essential
hypertension. Acta Cardiol 39(3):203–208
19. Murugesan R, Govindarajulu N, Bera TK (2000) Effect of
selected yogic practices on the management of hypertension.
Indian J Physiol Pharmacol 44(2):207–210
20. Canter PH, Ernst E (2004) Insufficient evidence to conclude
whether or not Transcendental Meditation decreases blood pres-
sure: results of a systematic review of randomized clinical trials.
J Hypertens 22(11):2049–2054
21. Parati G, Steptoe A (2004) Stress reduction and blood pressure
control in hypertension: a role for transcendental meditation?
J Hypertens 22(11):2057–2060
22. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR,
Cook JV et al (2006) Lifestyle interventions to reduce raised
blood pressure: a systematic review of randomized controlled
trials. J Hypertens 24(2):215–233
23. Manikonda JP, Stork S, Togel S, Lobmuller A, Grunberg I, Bedel
S et al (2008) Contemplative meditation reduces ambulatory
blood pressure and stress-induced hypertension: a randomized
pilot trial. J Hum Hypertens 22(2):138–140
24. Linden W, Lenz JW, Con AH (2001) Individualized stress
management for primary hypertension: a randomized trial. Arch
Intern Med 161(8):1071–1080
25. Carlson LE, Speca M, Faris P et al (2007) One year pre-post
intervention follow-up of psychological, immune, endocrine and
blood pressure outcomes of mindfulness-based stress reduction
(MBSR) in breast and prostate cancer outpatients. Brain Behav
Immun 21(8):1038–1049
26. Barnes VA, Davis HC, Murzynowski JB, Treiber FA (2004)
Impact of meditation on resting and ambulatory blood pressure
and heart rate in youth. Psychosom Med 66(6):909–914
27. Linden W, Moseley JV (2006) The efficacy of behavioral treat-
ments for hypertension. Appl Psychophysiol Biofeedback
31(1):51–63
28. Anderson JW, Liu C, Kryscio RJ (2008) Blood pressure response
to transcendental meditation: a meta-analysis. Am J Hypertens
21(3):310–316
29. Patel C, Marmot M, Terry D et al (1985) Trial of relaxation in
reducing coronary risk: four year follow-up. Br Med J
290:1103–1106
30. Rana Singh RK, Singh VK (2013) Clinical evaluation of some
yogic practices in the management of essential hypertension.
Indian Med J 107(3):105
31. Stamler J, Rose G, Stamler R, Elliott P, Dyer A, Marmot M
(1989) INTERSALT study findings. Public health and medical
care implications. Hypertension 14(5):570–577
32. Appel LJ (2003) Lifestyle modification as a means to prevent and
treat high blood pressure. J Am Soc Nephrol 14(7 Suppl 2):S99–
S102
33. Khatri D, Mathur KC, Gahlot S, Jain S, Agrawal RP (2007)
Effects of yoga and meditation on clinical and biochemical
parameters of metabolic syndrome. Diabetes Res Clin Pract
78:e9–e10
34. Cohen BE, Chang AA, Grady D, Kanaya AM (2008) Restorative
yoga in adults with metabolic syndrome: a randomized, con-
trolled pilot trial. Metab Syndr Relat Disord 6:223–229
35. Innes KE, Bourguignon C, Taylor AG (2005) Risk indices
associated with the insulin resistance syndrome, cardiovascular
disease, and possible protection with yoga: a systematic review.
J Am Board Fam Pract 18:491–519
36. Paul-Labrador M, Polk D, Dwyer JH, Velasquez I, Nidich S
et al (2006) Effects of a randomized controlled trial of tran-
scendental meditation on components of the metabolic syn-
drome in subjects with coronary heart disease. Arch Intern Med
166:1218–1224
37. Manchanda SC, Mehrotra UC, Makhija A, Mohanty A, Dhawan S
et al (2013) Reversal of early atherosclerosis in metabolic syn-
drome by yoga: a randomized controlled trial. J Yoga Phys Ther
3:132. doi:10.4172/2157-7595.1000132
38. Jain S, Uppal A, Bhatnagar S, Talukdar B (1993) A study of
response pattern of non-insulin dependent diabetics to yoga
therapy. Diabetes Res Clin Pract 19:69–74
39. Singh S, Malhotra V, Singh KP, Madhu SV, Tandon OP (2004)
Role of yoga in modifying certain cardiovascular functions in
type 2 diabetic patients. J Assoc Phys India 52:203–206
40. Malhotra V, Singh S, Tandon OP, Sharma SB (2005) The ben-
eficial effects of yoga in diabetes. Nepal Med Coll J 7:145–147
41. Kosuri M, Sridhar GR (2009) Yoga practice in diabetes improves
physical and psychological outcomes. Metab Syndr Relat Disord
7:515–517
42. Gordon LA, Morrison EY, McGrowder DA, Young R, Fraser YT,
Zamora EM et al (2008) Effects of exercise therapy on lipid
profile and oxidative stress indicators in patients with type 2
diabetes. BMC Complement Altern Med 13(8):21
43. Manchanda S, Narang R, Reddy K et al (2000) Retardation of
coronary atherosclerosis with yoga lifestyle intervention. J Assoc
Phys India 48:687–694
44. Mahajan A, Reddy K, Sachdeva U (1999) Lipid profile of coro-
nary risk subjects following yogic lifestyle intervention. Indian
Heart J 51(1):37–40
45. Udupa KN, Singh RH (1972) The scientific basis of yoga. JAMA
220:1365
46. Damodaran A, Malathi A, Patil N, Shah N, Suryavansihi Marathe
S (2002) Therapeutic potential of yoga practices in modifying
cardiovascular risk profile in middle aged men and women.
J Assoc Phys India 50:633–640
47. Joseph S, Sridharan K, Patil S et al (1981) Study of some
physiological and biochemical parameters in subjects undergoing
yogic training. Indian J Med Res 74:120–124
48. Patel C (1976) Reduction of serum cholesterol and blood pressure
in hypertensive patients by behaviour modification. J Roy Coll
Gen Pract 26:211–215
49. Naruka J, Mathur R, Mathur A (1986) Effect of pranayama
practices on fasting blood glucose and serum cholesterol. Indian J
Med Sci 40:149–152
50. Shantakumari N, Sequeira S, El Deeb R (2013) Effects of a yoga
intervention on lipid profiles of diabetes patients with dyslipi-
demia. Indian Heart J 65(2):127–131
51. Moan A, Nordby G, Rostrup M, Eide I, Kjeldsen SE (1995)
Insulin sensitivity, sympathetic activity, and cardiovascular
reactivity in young men. Am J Hypertens 8:268–275
52. Jennings JR, van der Molen MW, Somsen RJ, Graham R,
Gianaros PJ (2002) Vagal function in health and disease: studies
in Pittsburgh. Physiol Behav 77:693–698
53. Mezzacappa ES, Kelsey RM, Katkin ES, Sloan RP (2001) Vagal
rebound and recovery from psychological stress. Psychosom Med
63:650–657
54. Ceriello A, Motz E (2004) Is oxidative stress the pathogenic
mechanism underlying insulin resistance, diabetes and cardio-
vascular disease? The common soil hypothesis revisited. Arte-
rioscler Thromb Vasc Biol 24:816–823
55. Chohan IS, Nayar HS, Thomas P, Geetha NS (1984) Influence of
yoga on blood coagulation. Thromb Hemost 51:196–197
Clin Res Cardiol
123
56. Schmidt T, Wijga A, Von Zur Muhlen A, Brabant G, Wagner TO
(1997) Changes in cardiovascular risk factors and hormones
during a comprehensive residential three month kriya yoga
training and vegetarian nutrition. Acta Physiol Scand Suppl
640:158–162
57. Singh S, Malhotra V, Singh K, Sharma S (2001) A pre-liminary
report on the role of yoga asanas on oxi-dative stress in nonin-
sulin dependent diabetes. Indian J Clin Biochem 16:216–220
58. Bhattacharya S, Pandey U, Verma N (2002) Improvement in
oxidative status with yogic breathing in young healthy males.
Indian J Physiol Pharmacol 46:349–354
59. Sharma H, Sen S, Singh A, Bhardwaj NK, Kochupillai V, Singh
N (2003) Sudarshan kriya practitioners exhibit better antioxidant
status and lower blood lactate levels. Biol Psychol 63:281–291
60. Sinha S, Singh SN, Monga YP, Ray US (2007) Improvement of
glutathione and total antioxidant status with yoga. J Altern
Complement Med 13(10):1085–1090
61. Fields JZ, Walton KG, Schneider RH, Nidich S, Pomerantz R
et al (2002) Effect of a multimodality natural medicine program
on carotid atherosclerosis in older subjects: a pilot trial of
Maharishi Vedic Medicine. Am J Cardiol 89:952–958
62. Ornish D, Brown SE, Scherwitz LW, Billings JH, Armstrong WT
et al (1990) Can lifestyle changes reverse coronary heart disease?
The lifestyle heart trial. Lancet 336:129–133
63. Gupta SK, Sawhney RC, Rai L, Chavan VD, Dani S et al (2011)
Regression of coronary atherosclerosis through healthy lifestyle
in coronary artery disease patients–Mount Abu open heart trial.
Indian Heart J 63:461–469
64. Schneider RH, Grim CE, Rainforth MV, Kotchen T, Nidich SI
et al (2012) Stress reduction in the secondary prevention of
cardiovascular disease: randomized, controlled trial of transcen-
dental meditation and health education in Blacks. Circ Cardio-
vasc Qual Outcomes 5:750–758
65. Telles S, Naveen KV (1997) Yoga for rehabilitation: an over-
view. Indian J Med Sci 51(4):123–127
66. Raju PS, Madhavi S, Prasad KV, Reddy MV, Reddy ME, Sahay
BK, Murthy KJ (1994) Comparison of effects of yoga and
physical exercise in athletes. Indian J Med Res 100:81–86
67. Malathi A, Damodaran A, Shah N, Patil N, Maratha S (2000)
Effect of yogic practices on subjective well being. Indian J
Physiol Pharmacol 44(2):202–206
68. Tang YY, Tang R, Posner MI (2013) Brief meditation training
induces smoking reduction. Proc Natl Acad Sci USA 110(34):
13971–13975
69. Lakkireddy D, Atkins D, Pillarisetti J, Ryschon K, Bommana S,
Drisko J, Vanga S, Dawn B (2013) Effect of yoga on arrhythmia
burden, anxiety, depression, and quality of life in paroxysmal
atrial fibrillation: the YOGA My Heart Study. J Am Coll Cardiol
61(11):1177–1182
70. La Forge R (1997) Mind–body fitness: encouraging prospects for
primary and secondary prevention. J Cardiovasc Nurs 11(3):
53–65
Clin Res Cardiol
123